The long-term fate of Insite, Vancouver's supervised injection facility, remains in doubt. The federal government granted a 16-month renewal of Insite's exemption under Section 56 of the Controlled Drugs and Substances Act, but refused to grant the three-year exemption Insite was seeking. The government said that more information is needed on whether Insite has been successful, despite a slew of scientific studies that have demonstrated Insite's value in terms of both health and public safety.
